Study on Drug Interaction Between Esomeprazole and Anti-Diabetic Drugs
Author Information
Author(s): VKM Swamy, RS Setty, MM Shankaraiah, TM Jyothi, SV Rajendra
Primary Institution: S.C.S. College of Pharmacy, Harapanahalli
Hypothesis
Esomeprazole may influence the metabolism of sulfonylureas.
Conclusion
Therapeutic doses of esomeprazole do not influence hypoglycemia induced by sulfonylureas, but higher doses enhance the duration and peak of hypoglycemia.
Supporting Evidence
- Esomeprazole at therapeutic doses did not influence hypoglycemia induced by sulfonylureas.
- At a higher dose of 30 mg/kg, esomeprazole significantly enhanced the duration and peak of hypoglycemia.
- The study involved 36 albino rats divided into 6 groups for testing.
Takeaway
This study looked at how a heartburn medicine called esomeprazole affects diabetes medications. It found that normal doses don't change how well the diabetes meds work, but very high doses can make their effects stronger.
Methodology
Albino rats were used to study the effects of esomeprazole on hypoglycemia induced by tolbutamide and glibenclamide over an 8-day period.
Limitations
The study was conducted on animals, which may not fully represent human responses.
Participant Demographics
Albino rats of either sex, weighing 150–250 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website